Cancer therapy

Details for Australian Patent Application No. 2002248366 (hide)

Owner Duke University National Jewish Medical And Research Center Aeolus Sciences, Inc.

Inventors Crapo, James D.; Gammans, Richard; Day, Brian J.; Vujaskovic, Zeljko; Batinic-Haberle, Ines

Agent Cullen & Co

Pub. Number AU-B-2002248366

PCT Pub. Number WO2002/060383

Priority 60/262,390 19.01.01 US

Filing date 22 January 2002

Wipo publication date 12 August 2002

Acceptance publication date 26 October 2006

International Classifications

A61K 31/00 (2006.01)

Event Publications

20 February 2003 Application Open to Public Inspection

  Published as AU-B-2002248366

30 September 2004 Change of Name(s) of Applicant(s), Section 104

  National Jewish Medical And Research Center; Aeolus Pharmaceuticals, Inc.; Duke University The name of the applicant has been changed to Duke University; National Jewish Medical And Research Center; Aeolus Sciences, Inc.

26 October 2006 Application Accepted

  Published as AU-B-2002248366

22 February 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002248367-INHIBITION OF INTERLEUKIN1-BETA SECRETION BY CARD PROTEINS

2002248365-METHOD AND APPARATUS FOR PROVIDING AUTHENTICATION IN A COMMUNICATION SYSTEM